Through the 90-day period concluding December 12, 2025, Nuvalent's top three insider stakeholders include Director James E Flynn (8.30Mn shares), Director Matthew Shair (1.58Mn shares), President And CEO James Richard Porter (249.06K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| James E Flynn | 8,299,225 | 24 Nov, 2025 | |
| Matthew Shair | 1,578,866 | 26 Nov, 2025 | |
| Andrew A. F. Hack | 1,449,766 | 14 Jun, 2024 | |
| Biomedical Innovation Master Investors (Cayman) I L.P. Wellington | 897,671 | 03 Aug, 2021 | |
| James Richard Porter | President And CEO | 249,062 | 17 Oct, 2025 |
| Henry E. Pelish | Chief Scientific Officer | 65,963 | 17 Oct, 2025 |
| Christopher Durant Turner | Chief Medical Officer | 62,547 | 08 Jan, 2025 |
| Alexandra Balcom | Chief Financial Officer | 54,650 | 10 Dec, 2025 |
| Deborah Ann Miller | Chief Legal Officer | 49,086 | 19 Nov, 2025 |
| Darlene Noci | Chief Development Officer | 48,034 | 02 Dec, 2025 |
| Grant C. Bogle | 5,847 | 20 Jun, 2025 | |
| Sapna Srivastava | 5,146 | 20 Jun, 2025 | |
| Joseph Pearlberg | 5,146 | 20 Jun, 2025 | |
| Cameron Wheeler | 5,146 | 20 Jun, 2025 | |
| Anna Protopapas | 5,146 | 20 Jun, 2025 | |
| Michael L. Meyers | 5,146 | 20 Jun, 2025 | |
| Christy J. Oliger | 3,971 | 20 Jun, 2025 | |
| Ron Squarer | 2,837 | 11 Dec, 2025 | |
| Emily Conley | 2,507 | 27 Aug, 2024 | |
| Dwight Gary Gilliland | 2,499 | 14 Jun, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 10 Dec, 2025 | Ron Squarer | Class A Common Stock | A | 2,837 | $0.00 | 2,837 | D | A |
| 08 Dec, 2025 | Alexandra Balcom | Class A Common Stock | D | 6,984 | $110.31 | 54,750 | D | S |
| 08 Dec, 2025 | Alexandra Balcom | Class A Common Stock | D | 100 | $111.32 | 54,650 | D | S |
| 28 Nov, 2025 | Darlene Noci | Class A Common Stock | A | 4,000 | $27.85 | 52,034 | D | M |
| 28 Nov, 2025 | Darlene Noci | Class A Common Stock | D | 645 | $107.85 | 51,389 | D | S |
| 28 Nov, 2025 | Darlene Noci | Class A Common Stock | D | 3,355 | $108.72 | 48,034 | D | S |
| 24 Nov, 2025 | James E Flynn | Class A Common Stock | D | 371,287 | $95.44 | 8,299,225 | I | S |
| 24 Nov, 2025 | Matthew Shair | Class A Common Stock | D | 369 | $107.70 | 1,382,675 | D | S |
| 24 Nov, 2025 | James E Flynn | Class A Common Stock | D | 371,287 | $95.44 | 8,299,225 | I | S |
| 24 Nov, 2025 | Matthew Shair | Class A Common Stock | D | 104 | $107.70 | 203,218 | I | S |
| 24 Nov, 2025 | Matthew Shair | Class A Common Stock | D | 2,262 | $108.73 | 1,380,413 | D | S |
| 24 Nov, 2025 | Matthew Shair | Class A Common Stock | D | 638 | $108.73 | 202,580 | I | S |
| 24 Nov, 2025 | Matthew Shair | Class A Common Stock | D | 2,026 | $109.77 | 1,378,387 | D | S |
| 24 Nov, 2025 | Matthew Shair | Class A Common Stock | D | 572 | $109.77 | 202,008 | I | S |
| 24 Nov, 2025 | Matthew Shair | Class A Common Stock | D | 1,193 | $110.42 | 1,377,194 | D | S |
| 24 Nov, 2025 | Matthew Shair | Class A Common Stock | D | 336 | $110.42 | 201,672 | I | S |
| 17 Nov, 2025 | Alexandra Balcom | Class A Common Stock | A | 6,875 | $6.89 | 68,609 | D | M |
| 17 Nov, 2025 | Deborah Ann Miller | Class A Common Stock | A | 24,200 | $6.89 | 73,286 | D | M |
| 17 Nov, 2025 | Alexandra Balcom | Class A Common Stock | A | 13,125 | $72.35 | 81,734 | D | M |
| 17 Nov, 2025 | Deborah Ann Miller | Class A Common Stock | D | 15,075 | $105.16 | 58,211 | D | S |